Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words '4-GUANIDINO-NEU5AC2EN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 44 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Baigent, SJ; McCauley, JW
      Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture

      VIRUS RESEARCH
    2. Smee, DF; Sidwell, RW; Morrison, AC; Bailey, KW; Baum, EZ; Ly, L; Wagaman, PC
      Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201

      ANTIVIRAL RESEARCH
    3. Kobasa, D; Wells, K; Kawaoka, Y
      Amino acids responsible for the absolute sialidase activity of the influenza A virus neuraminidase: Relationship to growth in the duck intestine

      JOURNAL OF VIROLOGY
    4. Gubareva, LV; Kaiser, L; Matrosovich, MN; Soo-Hoo, Y; Hayden, FG
      Selection of influenza virus mutants in experimentally infected volunteerstreated with oseltamivir

      JOURNAL OF INFECTIOUS DISEASES
    5. Jackson, HC; Roberts, N; Wang, ZM; Belshe, R
      Management of influenza - Use of new antivirals and resistance in perspective

      CLINICAL DRUG INVESTIGATION
    6. Tisdale, M
      Monitoring of viral susceptibility: new challenges with the development ofinfluenza NA inhibitors

      REVIEWS IN MEDICAL VIROLOGY
    7. Lew, W; Chen, XW; Kim, CU
      Discovery and development of GS 4104 (oseltamivir): An orally active influenza neuraminidase inhibitor

      CURRENT MEDICINAL CHEMISTRY
    8. Arden, NH
      Control of influenza in the long-term-care facility: A review of established approaches and newer options

      INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
    9. Fladerer, P; Wenisch, C
      Neuraminidase inhibitors in the therapy of influenza

      ACTA MEDICA AUSTRIACA
    10. Kaverin, NV; Matrosovich, MN; Gambaryan, AS; Rudneva, IA; Shilov, AA; Varich, NL; Makarova, NV; Kropotkina, EA; Sinitsin, BV
      Intergenic HA-NA interactions in influenza A virus: postreassortment substitutions of charged amino acid in the hemagglutinin of different subtypes

      VIRUS RESEARCH
    11. Leneva, IA; Roberts, N; Govorkova, EA; Goloubeva, OG; Webster, RG
      The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses

      ANTIVIRAL RESEARCH
    12. McKimm-Breschkin, JL
      Resistance of influenza viruses to neuraminidase inhibitors - a review

      ANTIVIRAL RESEARCH
    13. Gubareva, LV; Kaiser, L; Hayden, FG
      Influenza virus neuraminidase inhibitors

      LANCET
    14. Barnett, JM; Cadman, A; Gor, D; Dempsey, M; Walters, M; Candlin, A; Tisdale, M; Morley, PJ; Owens, IJ; Fenton, RJ; Lewis, AP; Claas, ECJ; Rimmelzwaan, GF; De Groot, R; Osterhaus, ADME
      Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    15. Laver, WG; Bischofberger, N; Webster, RG
      The origin and control of pandemic influenza

      PERSPECTIVES IN BIOLOGY AND MEDICINE
    16. Hayden, FG; Gubareva, LV; Monto, AS; Klein, TC; Elliott, MJ; Hammond, JM; Sharp, SJ; Ossi, MJ
      Inhaled zanamivir for the prevention of influenza in families.

      NEW ENGLAND JOURNAL OF MEDICINE
    17. Mitnaul, LJ; Matrosovich, MN; Castrucci, MR; Tuzikov, AB; Bovin, NV; Kobasa, D; Kawaoka, Y
      Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus

      JOURNAL OF VIROLOGY
    18. Hughes, MT; Matrosovich, M; Rodgers, ME; McGregor, M; Kawaoka, Y
      Influenza A viruses lacking sialidase activity can undergo multiple cyclesof replication in cell culture, eggs, or mice

      JOURNAL OF VIROLOGY
    19. Boivin, G; Goyette, N; Hardy, I; Aoki, F; Wagner, A; Trottier, S
      Rapid antiviral effect of inhaled zanamivir in the treatment of naturally occurring influenza in otherwise healthy adults

      JOURNAL OF INFECTIOUS DISEASES
    20. Buxton, RC; Edwards, B; Juo, RR; Voyta, JC; Tisdale, M; Bethell, RC
      Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivir

      ANALYTICAL BIOCHEMISTRY
    21. Kim, CU; Chen, XW; Mendel, DB
      Neuraminidase inhibitors as anti-influenza virus agents

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    22. Colman, PM
      A novel approach to antiviral therapy for influenza

      Journal of antimicrobial chemotherapy
    23. Air, GM; Ghate, AA; Stray, SJ
      Influenza neuraminidase as target for antivirals

      ADVANCES IN VIRUS RESEARCH, VOL 54
    24. Barnett, JM; Cadman, A; Burrell, FM; Madar, SH; Lewis, AP; Tisdale, M; Bethell, R
      In vitro selection and characterisation of influenza B/Beijing/1/87 isolates with altered susceptibility to zanamivir

      VIROLOGY
    25. Baigent, SJ; Bethell, RC; McCauley, JW
      Genetic analysis reveals that both haemagglutinin and neuraminidase determine the sensitivity of naturally occurring avian influenza viruses to zanamivir in vitro

      VIROLOGY
    26. Rowley, KV; Harvey, R; Barclay, WS
      Isolation and characterization of a transfectant influenza B virus alteredin RNA segment 6

      JOURNAL OF GENERAL VIROLOGY
    27. MENDEL DB; SIDWELL RW
      INFLUENZA-VIRUS RESISTANCE TO NEURAMINIDASE INHIBITORS

      DRUG RESISTANCE UPDATES
    28. VARGHESE JN; SMITH PW; SOLLIS SL; BLICK TJ; SAHASRABUDHE A; MCKIMMBRESCHKIN JL; COLMAN PM
      DRUG DESIGN AGAINST A SHIFTING TARGET - A STRUCTURAL BASIS FOR RESISTANCE TO INHIBITORS IN A VARIANT OF INFLUENZA-VIRUS NEURAMINIDASE

      Structure
    29. Mendel, DB; Roberts, NA
      In-vitro and in-vivo efficacy of influenza neuraminidase inhibitors

      CURRENT OPINION IN INFECTIOUS DISEASES
    30. BANTIA S; GHATE AA; ANANTH SL; BABU YS; AIR GM; WALSH GM
      GENERATION AND CHARACTERIZATION OF A MUTANT OF INFLUENZA-A VIRUS SELECTED WITH THE NEURAMINIDASE INHIBITOR BCX-140

      Antimicrobial agents and chemotherapy
    31. Tai, CY; Escarpe, PA; Sidwell, RW; Williams, MA; Lew, W; Wu, HW; Kim, CU; Mendel, DB
      Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071.

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    32. SAHASRABUDHE A; LAWRENCE L; EPA VC; VARGHESE JN; COLMAN PM; MCKIMMBRESCHKIN JL
      SUBSTRATE, INHIBITOR, OR ANTIBODY STABILIZES THE GLU-119 GLY MUTANT INFLUENZA-VIRUS NEURAMINIDASE

      Virology (New York, N.Y. Print)
    33. BLICK TJ; SAHASRABUDHE A; MCDONALD M; OWENS IJ; MORLEY PJ; FENTON RJ; MCKIMMBRESCHKIN JL
      THE INTERACTION OF NEURAMINIDASE AND HEMAGGLUTININ MUTATIONS IN INFLUENZA-VIRUS IN RESISTANCE TO 4-GUANIDINO-NEU5AC2EN

      Virology (New York, N.Y. Print)
    34. KAVERIN NV; GAMBARYAN AS; BOVIN NV; RUDNEVA IA; SHILOV AA; KHODOVA OM; VARICH NL; SINITSIN BV; MAKAROVA NV; KROPOTKINA EA
      POSTREASSORTMENT CHANGES IN INFLUENZA-A VIRUS HEMAGGLUTININ RESTORINGHA-NA FUNCTIONAL MATCH

      Virology
    35. MCKIMMBRESCHKIN JL; SAHASRABUDHE A; BLICK TJ; MCDONALD M; COLMAN PM; HART GJ; BETHELL RC; VARGHESE JN
      MUTATIONS IN A CONSERVED RESIDUE IN THE INFLUENZA-VIRUS NEURAMINIDASEACTIVE-SITE DECREASES SENSITIVITY TO NEU5AC2EN-DERIVED INHIBITORS

      Journal of virology
    36. GUBAREVA LV; MATROSOVICH MN; BRENNER MK; BETHELL RC; WEBSTER RG
      EVIDENCE FOR ZANAMIVIR RESISTANCE IN AN IMMUNOCOMPROMISED CHILD INFECTED WITH INFLUENZA-B VIRUS

      The Journal of infectious diseases
    37. Gubareva, LV; McCullers, JA; Bethell, RC; Webster, RG
      Characterization of influenza A/HongKong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice

      JOURNAL OF INFECTIOUS DISEASES
    38. Ghate, AA; Air, GM
      Site-directed mutagenesis of catalytic residues of influenza virus neuraminidase as an aid to drug design

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    39. CALFEE DP; HAYDEN FG
      NEW APPROACHES TO INFLUENZA CHEMOTHERAPY - NEURAMINIDASE INHIBITORS

      Drugs
    40. GOTO H; BETHELL RC; KAWAOKA Y
      MUTATIONS AFFECTING THE SENSITIVITY OF THE INFLUENZA-VIRUS NEURAMINIDASE TO ANIDINO-2,4-DIDEOXY-2,3-DEHYDRO-N-ACETYLNEURAMINIC ACID

      Virology
    41. COLACINO JM; CHIRGADZE NY; GARMAN E; MURTI KG; LONCHARICH RJ; BAXTER AJ; STASCHKE KA; LAVER WG
      A SINGLE SEQUENCE CHANGE DESTABILIZES THE INFLUENZA-VIRUS NEURAMINIDASE TETRAMER

      Virology
    42. HART GJ; BETHELL RC
      YDRO-2,4-DIDEOXY-4-GUANIDINO-N-ACETYL-D-NEURAMINIC ACID (4-GUANIDINO-NEU5AC2EN) IS A SLOW-BINDING INHIBITOR OF SIALIDASE FROM BOTH INFLUENZA-A VIRUS AND INFLUENZA-B VIRUS

      Biochemistry and molecular biology international
    43. HAYDEN FG; ROLLINS BS; MADREN LK
      ANTIINFLUENZA VIRUS ACTIVITY OF THE NEURAMINIDASE INHIBITOR 4-GUANIDINO-NEUSAC2EN IN CELL-CULTURE AND IN HUMAN RESPIRATORY EPITHELIUM

      Antiviral research
    44. THOMAS GP; FORSYTH M; PENN CR; MCCAULEY JW
      INHIBITION OF THE GROWTH OF INFLUENZA-VIRUSES IN-VITRO BY 4-GUANIDINO-2,4-DIDEOXY-N-ACETYLNEURAMINIC ACID

      Antiviral research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 11/08/20 alle ore 06:41:40